Ian W. Flinn
- Genetics top 0.01%
- Pathology and Forensic Medicine top 0.02%
- Oncology top 0.2%
- Hematology top 0.05%
- Immunology top 0.2%
- Co-authors
- John C. ByrdMichael R. GreverSteven CoutréR. KantiBrad S. KahlRichard R. FurmanRichard F. AmbinderRichard A. Larson
- Topics
- Chronic Lymphocytic Leukemia Research (369 papers)Lymphoma Diagnosis and Treatment (295 papers)CAR-T cell therapy research (85 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Ian W. Flinn
524 papers receiving 18.4k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Genetics 11.5k
- Pathology and Forensic Medicine 10.1k
- Oncology 6.0k
- Hematology 5.4k
- Immunology 4.7k
Countries citing papers authored by Ian W. Flinn
This map shows the geographic impact of Ian W. Flinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian W. Flinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian W. Flinn more than expected).
Fields of papers citing papers by Ian W. Flinn
This network shows the impact of papers produced by Ian W. Flinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian W. Flinn. The network helps show where Ian W. Flinn may publish in the future.
Co-authorship network of co-authors of Ian W. Flinn
This figure shows the co-authorship network connecting the top 25 collaborators of Ian W. Flinn. A scholar is included among the top collaborators of Ian W. Flinn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian W. Flinn. Ian W. Flinn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 2 | |
| 4 | 34 | |
| 5 | 15 | |
| 6 | 15 | |
| 7 | 10 | |
| 8 | 2 | |
| 9 | 22 | |
| 10 | 126 | |
| 11 | 27 | |
| 12 | 20 | |
| 13 | 33 | |
| 14 | 47 | |
| 15 | 183 | |
| 16 | 112 | |
| 17 | Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT studybreakdown → | 419 |
| 18 | 256 | |
| 19 | 300 | |
| 20 | 306 |
About Ian W. Flinn
Ian W. Flinn is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 542 papers that have together received 18.8k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (369 papers), Lymphoma Diagnosis and Treatment (295 papers) and CAR-T cell therapy research (85 papers). The work is most often cited by research in Genetics (11.5k citations), Pathology and Forensic Medicine (10.1k citations) and Hematology (5.4k citations). Ian W. Flinn has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include John C. Byrd, Michael R. Grever, Steven Coutré, R. Kanti, Brad S. Kahl, Richard R. Furman, Richard F. Ambinder, Richard A. Larson, Thomas J. Kipps and John C. Byrd. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.